Nexavar
Nexavar Official FDA information, side effects and uses.
Posted by Nexavar (Nexavar) on Tue, 21 Aug 2007 13:02:55 +0000
Forbes - LEVERKUSEN, Germany (Thomson Financial) - Bayer AG and US company Onyx Pharmaceuticals Inc said their application for Nexavar to be approved as a treatment of hepatocellular carcinoma, the most common form of liver cancer, has been accepted for ...
Nexavar Granted FDA Priority Review for Treatment of Liver Cancer
Earthtimes - WAYNE, N.J., and EMERYVILLE, Calif., Aug. 20 -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the supplemental New Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets for the treatment of patients with ...
FDA gives Onyx liver cancer drug priority review
Reuters - BOSTON, Aug 20 (Reuters) - Onyx Pharmaceuticals Inc. (ONXX.O: Quote , Profile , Research ) and German partner Bayer AG (BAYG.DE: Quote , Profile , Research ) said on Monday that U.S. regulators agreed to review their drug Nexavar as a treatment for ...
Bayer HealthCare (BAY) and Onyx (ONXX) Announce FDA Grants Priority ...
StreetInsider.com - Bayer HealthCare (BAY) and Onyx (ONXX) Announce FDA Grants Priority Review for Nexavar in Treatment of Liver Cancer Dendreon (DNDN) Announces Positive Phase 1 Study of Neuvenge in Breast Cancer Indevus Phama (IDEV) Receives FDA 'Approvable Letter ...
Onyx, Bayer Drug Gets Priority Review
Forbes - Bayer AG and Onyx Pharmaceuticals Inc. said Monday the Food and Drug Administration gave priority review for the application of its drug Nexavar as a liver cancer treatment. The drug is already approved in more than 50 countries to treat advanced ...
